ArticlePharmaceutics2020

TMS-Induced Controlled BBB Opening: Preclinical Characterization and Implications for Treatment of Brain Cancer.

Udi Vazana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.